Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Harvard Business School
AstraZeneca
McKesson
Dow

Last Updated: July 1, 2022

CLINICAL TRIALS PROFILE FOR MISOPROSTOL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Misoprostol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00097123 ↗ RCT of Misoprostol for Postpartum Hemorrhage in India Completed Bill and Melinda Gates Foundation N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗ RCT of Misoprostol for Postpartum Hemorrhage in India Completed Fogarty International Center of the National Institute of Health N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗ RCT of Misoprostol for Postpartum Hemorrhage in India Completed Global Network for Women's and Children's Health Research N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Misoprostol

Condition Name

Condition Name for Misoprostol
Intervention Trials
Postpartum Hemorrhage 39
Cervical Ripening 22
Pregnancy 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Misoprostol
Intervention Trials
Hemorrhage 93
Postpartum Hemorrhage 67
Abortion, Spontaneous 28
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Misoprostol

Trials by Country

Trials by Country for Misoprostol
Location Trials
United States 196
Egypt 112
France 15
India 13
Vietnam 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Misoprostol
Location Trials
California 24
Pennsylvania 18
New York 14
Texas 13
Massachusetts 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Misoprostol

Clinical Trial Phase

Clinical Trial Phase for Misoprostol
Clinical Trial Phase Trials
Phase 4 119
Phase 3 75
Phase 2/Phase 3 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Misoprostol
Clinical Trial Phase Trials
Completed 255
Unknown status 63
Recruiting 39
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Misoprostol

Sponsor Name

Sponsor Name for Misoprostol
Sponsor Trials
Gynuity Health Projects 61
Cairo University 37
Ain Shams University 27
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Misoprostol
Sponsor Trials
Other 618
Industry 19
NIH 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Medtronic
Harvard Business School
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.